Pharmaceutical

Charles River and Wheeler Bio partner on therapeutic discovery

Charles River has entered into a partnership with Wheeler Bio to expedite the progression from therapeutic discovery to manufacturing.

Feb 22, 2024 - 18:00
Charles River and Wheeler Bio partner on therapeutic discovery
Charles River has entered into a partnership with Wheeler Bio to expedite the progression from therapeutic discovery to manufacturing.
Read the original article

Tags:

Previous Article

Telehealth abortion is an “effective, safe” tool for equitable healthcare – US s...

Next Article

FDA accepts Regeneron’s BLA for linvoseltamab for review

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Ventyx stock craters after lackluster mid-stage trial results for psoriasis drug

STAT+: Ventyx stock craters after lackluster mid-stage ...

Nov 7, 2023

Boehringer and Lilly gain FDA approval for kidney disease therapy

Boehringer and Lilly gain FDA approval for kidney disea...

Sep 25, 2023

Will WHO’s new guidance spur hepatitis B immunisation?

Will WHO’s new guidance spur hepatitis B immunisation?

Jun 22, 2024